ojrdrtОнкологический журнал: лучевая диагностика, лучевая терапияJournal of oncology: diagnostic radiology and radiotherapy2587-75932713-167XНЕКОММЕРЧЕСКОЕ ПАРТНЕРСТВО «ОБЩЕСТВО ИНТЕРВЕНЦИОННЫХ ОНКОРАДИОЛОГОВ»10.37174/2587-7593-2026-9-2-15-27ojrdrt-542Research ArticleЯДЕРНАЯ МЕДИЦИНАNUCLEAR MEDICINEОценка ПЭТ/КТ в России на основе данных сети «ПЭТ-Технолоджи» (2021–2024 гг.)Assessment of PET/CT in Russia Based on Data from the «PET-Technology» Network (2021–2024)https://orcid.org/0000-0002-3621-1876АладинА. С.AladinA. S.

Аладин Александр Сергеевич

117485, Москва, ул. Профсоюзная, 86, стр. 3

+79683392368

Alexander S. Aladin

86, Bldg. 3, Profsoyuznaya Str., Moscow, 117485

aladindoctorru@gmail.comhttps://orcid.org/0000-0001-5994-0468НудновН. В.NudnovN. V.

117997, Москва, ул. Профсоюзная, 86

Nikolai V. Nudnov

86 Profsoyuznaya Str., Moscow, 117997

https://orcid.org/0009-0002-7954-2402АладинП. А.AladinP. A.

127994, Москва, ул. Образцова, 9, стр. 9

Platon A. Aladin

9, Bldg. 9, Obraztsova Str., Moscow, 127994

Обособленное подразделение «Центр ядерной медицины и диагностики г. Москва» Акционерного общества «Клиника К+31»РоссияBranc «Center of Nuclear Medicine and Diagnostics, Moscow» of «K+31 Clinic»Russian FederationРоссийский научный центр рентгенорадиологии Минздрава РоссииРоссияRussian Scientific Center of RoentgenoradiologyRussian FederationРоссийский университет транспорта, Институт управления и цифровых технологийРоссияInstitute of Management and Digital Technologies, Russian University of TransportRussian Federation202614062026921527Copyright © Аладин А.С., Нуднов Н.В., Аладин П.А., 20262026Аладин А.С., Нуднов Н.В., Аладин П.А.Aladin A.S., Nudnov N.V., Aladin P.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.oncoradjournal.ru/jour/article/view/542Актуальность

Актуальность: Несмотря на глобальный рост клинического применения ПЭТ/КТ-диагностики, в Российской Федерации отсутствуют систематизированные данные о её региональной распространенности и операционной динамике.

Цель исследования

Цель исследования: Провести комплексный анализ количественных и качественных показателей функционирования сети ПЭТ/КТ-центров «ПЭТ-Технолоджи» в России за 2021–2024 гг.

Материалы и методы

Материалы и методы: Методом сплошного наблюдения проанализировали данные из 29 регионов (6 федеральных округов) по ключевым индикаторам: динамике объемов исследований, плотности оборудования по федеральным округам, распределению клинических целей диагностики и спектру применяемых РФП.

Результаты

Результаты: Выявлен рост абсолютных объёмов исследований, однако относительные показатели достоверно снизились (p < 0,05), что отражает региональные диспропорции. Клиническая практика соответствует мировым стандартам. Более 35 % исследований направлены на мониторинг терапии при злокачественных новообразованиях. Неонкологические показания практически отсутствуют. При этом 98,7 % исследований выполняются с 18F-ФДГ.

Выводы

Выводы: Полученные результаты могут служить ориентиром для планирования в частном секторе и стимулом для создания национальной системы мониторинга, оптимизации территориального планирования и повышения равенства доступа к ядерной диагностике.

Relevance

Relevance: Despite the global expansion of PET/CT diagnostics, systematic data on its regional distribution and operational dynamics in the Russian Federation remain lacking.

Purpose

Purpose: To conduct a comprehensive analysis of quantitative and qualitative indicators of the «PET-Technology» PET/CT network performance in Russia from 2021 to 2024.

Materials and methods

Materials and methods: A complete enumeration observational study was performed using data from 29 regions across 6 federal districts, focusing on key indicators: trends in imaging volumes, equipment density by federal district, distribution of clinical diagnostic purposes, and the spectrum of radiopharmaceuticals used.

Results

Results: Absolute imaging volumes demonstrated growth; however, relative accessibility indicators significantly declined (p < 0.05), reflecting deepening regional disparities. Clinical practice aligns with international standards. More than 35 % of studies are dedicated to therapy monitoring in malignant neoplasms. Non-oncological indications are virtually absent (<0.3 %). Furthermore, 98.7 % of PET/ CT studies were performed using 18F-FDG.

Conclusions

Conclusions: These findings may serve as a reference for private-sector planning and as a catalyst for establishing a national PET/CT monitoring system, optimizing territorial resource allocation, and improving equity in access to nuclear diagnostics.

ядерная медицинаПЭТ/КТ18F-ФДГонкологическая диагностикарегиональное распределение ресурсовдоступность медицинской помощиоперационные показателичастный сектор в здравоохранениисистема обязательного медицинского страхованияnuclear medicinePET/CT18F-FDGoncological diagnosticsregional resource distributionaccess to medical careoperational performance indicatorsprivate healthcare sectorcompulsory health insuranceПроект ГК МедИнвестГрупп (https://www.pet-net.ru/projects)Project of MedInvestGroup Group (https://www.pet-net.ru/projects)ReferencesMeikle SR, Sossi V, Roncali E, et al. Quantitative PET in the 2020s: a roadmap. Physics in Medicine and Biology. 2021;66(6):06RM01. https://doi.org/10.1088/1361-6560/abd4f7.Meikle SR, Sossi V, Roncali E, et al. Quantitative PET in the 2020s: a roadmap. Physics in Medicine and Biology. 2021;66(6):06RM01. https://doi.org/10.1088/1361-6560/abd4f7.Hansen SB, Bender D. Advancement in Production of Radiotracers. Seminars in Nuclear Medicine. 2022;52(3):266-75. https://doi.org/10.1053/j.semnuclmed.2021.10.003.Hansen SB, Bender D. Advancement in Production of Radiotrac­ers. Seminars in Nuclear Medicine. 2022;52(3):266-75. https://doi.org/10.1053/j.semnuclmed.2021.10.003.Belcari N, Bisogni MG, Del Guerra A. Positron emission tomography: its 65 years and beyond. Riv Nuovo Cim. 2023;46:693-785. https://doi.org/10.1007/s40766-024-00050-3.Belcari N, Bisogni MG, Del Guerra A. Positron emission tomography: its 65 years and beyond. Riv Nuovo Cim. 2023;46:693-785. https://doi.org/10.1007/s40766-024-00050-3.Petersen H, Holdgaard PC, Madsen PH, et al. FDG PET/CT in cancer: comparison of actual use with literature-based recommendations. Eur J Nucl Med Mol Imaging. 2016;43(4):695-706. https://doi.org/10.1007/s00259-015-3217-0.Petersen H, Holdgaard PC, Madsen PH, et al. FDG PET/CT in cancer: comparison of actual use with literature-based recommendations. Eur J Nucl Med Mol Imaging. 2016;43(4):695-706. https://doi.org/10.1007/s00259-015-3217-0.Ebner R, Sheikh GT, Brendel M, et al. ESR Essentials: staging and restaging with FDG-PET/CT in oncology — practice recommendations by the European Society for Hybrid, Molecular and Translational Imaging. Eur Radiol. 2025;35:1894-902. https://doi.org/10.1007/s00330-024-11094-8.Ebner R, Sheikh GT, Brendel M, et al. ESR Essentials: staging and re­staging with FDG-PET/CT in oncology — practice recommendations by the European Society for Hybrid, Molecular and Translational Imaging. Eur Radiol. 2025;35:1894-902. https://doi.org/10.1007/s00330-024-11094-8.Ambrosini V, Kunikowska J, Baudin E, et al. Consensus on molecular imaging and theranostics in neuroendocrine neoplasms. Eur J Cancer. 2021;146:56-73. https://doi.org/10.1016/j.ejca.2021.01.008.Ambrosini V, Kunikowska J, Baudin E, et al. Consensus on molecular imaging and theranostics in neuroendocrine neoplasms. Eur J Can­cer. 2021;146:56-73. https://doi.org/10.1016/j.ejca.2021.01.008.Солодкий ВА, Фомин ДК. Современные тенденции развития ядерной медицины в Российской Федерации и мире в целом. Вопросы онкологии. 2009;55(4):413-5. EDN KYLPIB.Solodkiy VA, Fomin DK. Present-day trends in development of nuclear medicine in the russian federation and the world at large. Problems Of Oncology. 2009;55(4):413-5. EDN KYLPIB. (In Russ.).Cabras S, Manera U, Di Pede F, et al. Role of 2-[18F]FDG-PET as a biomarker of upper motor neuron involvement in amyotrophic lateral sclerosis. Journal of neurology. 2025;272(12):766. https://doi.org/10.1007/s00415-025-13501-6.Cabras S, Manera U, Di Pede F, et al. Role of 2-[18F]FDG-PET as a biomarker of upper motor neuron involvement in amyotrophic lat­eral sclerosis. Journal of neurology. 2025;272(12):766. https://doi.org/10.1007/s00415-025-13501-6.Yamanaka K, Okada K, Kato D, et al. Usefulness of 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Establishing the Optimal Surgical Strategy for Prosthetic Aortic Graft Infection. European journal of cardio-thoracic surgery. 2025;67(12):ezaf374. https://doi.org/10.1093/ejcts/ezaf374.Yamanaka K, Okada K, Kato D, et al. Usefulness of 18-Fluorodeox­yglucose Positron Emission Tomography/Computed Tomography in Establishing the Optimal Surgical Strategy for Prosthetic Aor­tic Graft Infection. European journal of cardio-thoracic surgery. 2025;67(12):ezaf374. https://doi.org/10.1093/ejcts/ezaf374.Greuez C, Lorenzo-Villalba N, Bessac DM, et al. Interest of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Fever and Inflammatory Syndrome of Unknown Origin in Elderly Patients: A Retrospective Real-Life Single-Center Study from a University Referral Hospital. J Clin Med. 2025;14(4):1188. https://doi.org/10.3390/jcm14041188.Greuez C, Lorenzo-Villalba N, Bessac DM, et al. Interest of 18F-Fluo­rodeoxyglucose Positron Emission Tomography/Computed Tomog­raphy for Fever and Inflammatory Syndrome of Unknown Origin in Elderly Patients: A Retrospective Real-Life Single-Center Study from a University Referral Hospital. J Clin Med. 2025;14(4):1188. https://doi.org/10.3390/jcm14041188.Debus J, von Götze I, Brandt J, et al. 68Ga-FAPI PET/CT for non-invasive characterization and activity assessment of ulcerative colitis and Crohn´s disease. Eur J Nucl Med Mol Imaging. 2026. https://doi.org/10.1007/s00259-025-07686-1.Debus J, von Götze I, Brandt J, et al. 68Ga-FAPI PET/CT for non-in­vasive characterization and activity assessment of ulcerative colitis and Crohn´s disease. Eur J Nucl Med Mol Imaging. 2026. https://doi.org/10.1007/s00259-025-07686-1.Joseph J, Birnie D, Nery PB, et al. Positive fluorodeoxyglucose positron emission tomography in Lyme myocarditis: A case report. HeartRhythm case reports. 2025;11(12):1359-1362. https://doi.org/10.1016/j.hrct.2025.10.002.Joseph J, Birnie D, Nery PB, et al. Positive fluorodeoxyglucose pos­itron emission tomography in Lyme myocarditis: A case report. HeartRhythm case reports. 2025;11(12):1359-1362. https://doi.org/10.1016/j.hrct.2025.10.002.Аншелес АА, Шимчук ГГ, Брускин АБ, и др. Перспективы возможностей визуализации атеросклероза методом позитронно-эмиссионной томографии в Российской Федерации. Атеросклероз и дислипидемии. 2022;(4):5-9.Ansheles AA, Shimchuk GG, Bruskin AB, et al. Prospects for imaging atherosclerosis using positron emission tomography in the Russian Federation. Aterosklerosis and Dislipidemy. 2022;(4):5-9. https://doi.org/10.34687/2219-8202.JAD.2022.04.0001. (In Russ.).Nag S, Stepanov V, Takano A, et al. Development of 18F/11C-Labeled Pyrrolo-Pyridine/Pyrimidine LRRK2 Selective PET Radioligands. Pharmaceuticals. 2025;18(12):1790. https://doi.org/10.3390/ph18121790.Nag S, Stepanov V, Takano A, et al. Development of 18F/11C-Labe­led Pyrrolo-Pyridine/Pyrimidine LRRK2 Selective PET Radioligands. Pharmaceuticals. 2025;18(12):1790. https://doi.org/10.3390/ph18121790.Bentestuen M, Dahlsgaard-Wallenius S, Stolberg MMK, et al. Nonmalignant findings on FAPI PET: An updated rapid systematic review of the literature. Semin Nucl Med. 2025. Advance online publication. https://doi.org/10.1053/j.semnuclmed.2025.11.015.Bentestuen M, Dahlsgaard-Wallenius S, Stolberg MMK, et al. Non­malignant findings on FAPI PET: An updated rapid systematic review of the literature. Semin Nucl Med. 2025. Advance online publication. https://doi.org/10.1053/j.semnuclmed.2025.11.015.Wang G, Lai Y, Chen D, et al. First-in-Human PET Imaging of Prostate Cancer Using [68Ga]Ga-AZ-093 and Its Nitroimidazole-Conjugated Derivative [68Ga]Ga-AZ-NI-093. Journal of nuclear medicine. 2026;67(1):105-112. https://doi.org/10.2967/jnumed.125.270703.Wang G, Lai Y, Chen D, et al. First-in-Human PET Imaging of Pros­tate Cancer Using [68Ga]Ga-AZ-093 and Its Nitroimidazole-Conju­gated Derivative [68Ga]Ga-AZ-NI-093. Journal of nuclear medicine. 2026;67(1):105-112. https://doi.org/10.2967/jnumed.125.270703.Zhao M, Wei H, Wang M, et al. Molecular imaging of fibroblast activation in systemic sclerosis using [18F]AlF-NOTA-FAPI-04 PET/CT: a prospective cohort study. Eur J Nucl Med Mol Imaging. 2025. Advance online publication. https://doi.org/10.1007/s00259-025-07586-4.Zhao M, Wei H, Wang M, et al. Molecular imaging of fibroblast ac­tivation in systemic sclerosis using [18F]AlF-NOTA-FAPI-04 PET/CT: a prospective cohort study. Eur J Nucl Med Mol Imaging. 2025. Advance online publication. https://doi.org/10.1007/s00259-025-07586-4.Kirienko M, Gelardi F, Fiz F, et al. Personalised PET imaging in oncology: an umbrella review of meta-analyses to guide the appropriate radiopharmaceutical choice and indication. Eur J Nucl Med Mol Imaging. 2024;52(1):208-224. https://doi.org/10.1007/s00259-024-06882-9.Kirienko M, Gelardi F, Fiz F, et al. Personalised PET imaging in oncol­ogy: an umbrella review of meta-analyses to guide the appropriate radiopharmaceutical choice and indication. Eur J Nucl Med Mol Im­aging. 2024;52(1):208-224. https://doi.org/10.1007/s00259-024-06882-9.Giammarile F, Castellucci P, Dierckx R, et al. Non-FDG PET/CT in Diagnostic Oncology: a pictorial review. European J Hybrid Imaging. 2019;3(1):20. https://doi.org/10.1186/s41824-019-0066-2.Giammarile F, Castellucci P, Dierckx R, et al. Non-FDG PET/CT in Di­agnostic Oncology: a pictorial review. European J Hybrid Imaging. 2019;3(1):20. https://doi.org/10.1186/s41824-019-0066-2.Zhang M, Qian J, Jia Y, et al. Translocator Protein 18 kDa-Targeted Total-Body PET Imaging Reveals Immune-Specific Vascular Inflammation in Large-Vessel Vasculitis: A Prospective Head-to-Head Comparison with 18F-FDG. Journal Nucl Med. 2025. Advance online publication. https://doi.org/10.2967/jnumed.125.270910.Zhang M, Qian J, Jia Y, et al. Translocator Protein 18 kDa-Targeted Total-Body PET Imaging Reveals Immune-Specific Vascular Inflamma­tion in Large-Vessel Vasculitis: A Prospective Head-to-Head Compar­ison with 18F-FDG. Journal Nucl Med. 2025. Advance online publica­tion. https://doi.org/10.2967/jnumed.125.270910.Godinez F, Mingels C, Bayerlein R, et al. Total Body PET/CT: Future Aspects. Sem Nucl Med. 2025;55(1):107-115. https://doi.org/10.1053/j.semnuclmed.2024.10.011.Godinez F, Mingels C, Bayerlein R, et al. Total Body PET/CT: Fu­ture Aspects. Sem Nucl Med. 2025;55(1):107-115. https://doi.org/10.1053/j.semnuclmed.2024.10.011.Aide N, Lason C, Desmonts C, et al. Advances in PET/CT Technology: An Update. Sem Nucl Med. 2022;52(3):286-301. https://doi.org/10.1053/j.semnuclmed.2021.10.005.Aide N, Lason C, Desmonts C, et al. Advances in PET/CT Technolo­gy: An Update. Sem Nucl Med. 2022;52(3):286-301. https://doi.org/10.1053/j.semnuclmed.2021.10.005.Islam MR, Zohra FT, Watabe H. Current Applications and Advancements of State-of-the-Art technology of PET-CT. Bangladesh J Nucl Med. 2025;28(1):149-155. https://doi.org/10.3329/bjnm.v28i1.79547.Islam MR, Zohra FT, Watabe H. Current Applications and Advance­ments of State-of-the-Art technology of PET-CT. Bangladesh J Nucl Med. 2025;28(1):149-155. https://doi.org/10.3329/bjnm.v28i1.79547.Grigoryan A, Bouyoucef S, Sathekge M, et al. Development of nuclear medicine in Africa. Clin Transl Imaging. 2022;10:101-111. https://doi.org/10.1007/s40336-021-00468-3.Grigoryan A, Bouyoucef S, Sathekge M, et al. Development of nucle­ar medicine in Africa. Clin Transl Imaging. 2022;10:101-111. https://doi.org/10.1007/s40336-021-00468-3.Okizaki A, Nishiyama Y, Inui Y, et al. Nuclear medicine practice in Japan: a report of the ninth nationwide survey in 2022. Ann Nucl Med. 2024;38(4):315-327. https://doi.org/10.1007/s12149-024-01905-9.Okizaki A, Nishiyama Y, Inui Y, et al. Nuclear medicine practice in Ja­pan: a report of the ninth nationwide survey in 2022. Ann Nucl Med. 2024;38(4):315-327. https://doi.org/10.1007/s12149-024-01905-9.Adam J, Svobodník A, Štěpánová R, et al. Analysis of progression of number and structure of scans performed using PET, PET/CT and PET/MRI in the Czech Republic in 2013–2021. Klin Onkol. 2024;37(4):259-269. https://doi.org/10.48095/ccko2024259.Adam J, Svobodník A, Štěpánová R, et al. Analysis of progres­sion of number and structure of scans performed using PET, PET/CT and PET/MRI in the Czech Republic in 2013–2021. Klin Onkol. 2024;37(4):259-269. https://doi.org/10.48095/ccko2024259.Gallach M, Mikhail Lette M, Abdel-Wahab M, et al. Addressing Global Inequities in Positron Emission Tomography-Computed Tomography (PET-CT) for Cancer Management: A Statistical Model to Guide Strategic Planning. Medical science monitor. 2020;26:e926544. https://doi.org/10.12659/MSM.926544.Gallach M, Mikhail Lette M, Abdel-Wahab M, et al. Addressing Glob­al Inequities in Positron Emission Tomography-Computed Tomogra­phy (PET-CT) for Cancer Management: A Statistical Model to Guide Strategic Planning. Medical science monitor. 2020;26:e926544. https://doi.org/10.12659/MSM.926544.Das KJ, Meena JK, Singhal A. Nuclear Oncology in Northeast India: Current scenario, challenges, and way forward. Ann Oncol Res Ther. 2022;2(2):71-76. https://doi.org/10.4103/aort.aort_19_22.Das KJ, Meena JK, Singhal A. Nuclear Oncology in Northeast India: Current scenario, challenges, and way forward. Ann Oncol Res Ther. 2022;2(2):71-76. https://doi.org/10.4103/aort.aort_19_22.Holzgreve A, Hellwig D, Barthel H, et al. PET imaging utilization and trends in Germany: a comprehensive survey. Eur J Nucl Med Mol Imaging. 2025;52(12):4390-4398. https://doi.org/10.1007/s00259-025-07323-x.Holzgreve A, Hellwig D, Barthel H, et al. PET imaging utilization and trends in Germany: a comprehensive survey. Eur J Nucl Med Mol Imaging. 2025;52(12):4390-4398. https://doi.org/10.1007/s00259-025-07323-x.Canadian Medical Imaging Inventory 2022–2023: PET-CT and PET-MRI: CMII Report. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2024 Aug. Report No.: HC0024-04. PMID: 39312604. Bookshelf ID: NBK607342.Canadian Medical Imaging Inventory 2022–2023: PET-CT and PET-MRI: CMII Report. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2024 Aug. Report No.: HC0024-04. PMID: 39312604. Bookshelf ID: NBK607342.Lynch C, Reguilon I, Langer DL, et al. A comparative analysis: international variation in PET-CT service provision in oncology-an International Cancer Benchmarking Partnership study. International J for Quality in Health Care. 2021;33(1):mzaa166. https://doi.org/10.1093/intqhc/mzaa166.Lynch C, Reguilon I, Langer DL, et al. A comparative analysis: inter­national variation in PET-CT service provision in oncology-an In­ternational Cancer Benchmarking Partnership study. Internation­al J for Quality in Health Care. 2021;33(1):mzaa166. https://doi.org/10.1093/intqhc/mzaa166.Chao YS, Sinclair A, Morrison A, et al. The Canadian Medical Imaging Inventory 2019–2020. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2021 Jan. PMID: 34990091. Bookshelf ID: NBK576053.Chao YS, Sinclair A, Morrison A, et al. The Canadian Medical Imag­ing Inventory 2019–2020. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2021 Jan. PMID: 34990091. Bookshelf ID: NBK576053.Шимчук ГГ, Брускин АБ, Шимчук Г.Г. Возможности и перспективы создания ПЭТ-центров в России на основе генераторных радионуклидов. Медицинская радиология и радиационная безопасность. 2022;67(6):62-66.Shimchuk GG, Bruskin AB, Shimchuk GrG. Opportunities and Prospects for Russia to Create PET Centers Based on Generator Radionuclides. Medical Radiology and Radiation Safety. 2022;67(6):62-66. https://doi.org/10.33266/1024-6177-2022-67-6-62-66. (In Russ.).Kennedy-Dixon TG, McDonnough K, Reid M, et al. Trends in the utilization of nuclear medicine technology in Jamaica: Audit of a private facility. World J Nucl Med. 2020;20(2):129-132. https://doi.org/10.4103/wjnm.WJNM_92_20.Kennedy-Dixon TG, McDonnough K, Reid M, et al. Trends in the uti­lization of nuclear medicine technology in Jamaica: Audit of a pri­vate facility. World J Nucl Med. 2020;20(2):129-132. https://doi.org/10.4103/wjnm.WJNM_92_20.Yoon J, Kim H, Woo DH, et al. F-18 FDG PET/CT Clinical Service Trends in Korea from 2018 to 2022: A National Surveillance Study. Nucl Med Mol Imaging. 2025;59(2):117-124. https://doi.org/10.1007/s13139-024-00898-7.Yoon J, Kim H, Woo DH, et al. F-18 FDG PET/CT Clinical Service Trends in Korea from 2018 to 2022: A National Surveillance Study. Nucl Med Mol Imaging. 2025;59(2):117-124. https://doi.org/10.1007/s13139-024-00898-7.Graham MM. The Future of Nuclear Medicine in the United States. J Nucl Med. 2023;64(9):1352-1353. https://doi.org/10.2967/jnumed.122.265314.Graham MM. The Future of Nuclear Medicine in the United States. J Nucl Med. 2023;64(9):1352-1353. https://doi.org/10.2967/jnumed.122.265314.Lawal IO. Nuclear Medicine Training: Skills and Competencies Required for Practice in the 21st Century. World J Nucl Med. 2023;22(2):75-77. https://doi.org/10.1055/s-0043-1769588.Lawal IO. Nuclear Medicine Training: Skills and Competencies Required for Practice in the 21st Century. World J Nucl Med. 2023;22(2):75-77. https://doi.org/10.1055/s-0043-1769588.Gremillet E, Lemaire B, Prigent A, et al. Nuclear medicine training and practice in France. Eur J Nucl Med Mol Imaging. 2013;40(6):976-978. https://doi.org/10.1007/s00259-013-2352-8.Gremillet E, Lemaire B, Prigent A, et al. Nuclear medicine training and practice in France. Eur J Nucl Med Mol Imaging. 2013;40(6):976-978. https://doi.org/10.1007/s00259-013-2352-8.Чипига ЛА, Ладанова ЕР, Водоватов АВ, и др. Тенденции развития ядерной медицины в Российской Федерации за 2015–2020 гг. Радиационная гигиена. 2022;15(4):122-33.Chipiga LA, Ladanova ER, Vodovatov AV, et al. Trends in the development of nuclear medicine in the Russian Federation for 2015–2020. Radiation Hygiene. 2022;15(4):122-33. https://doi.org/10.21514/1998-426X-2022-15-4-122-133. (In Russ.).Чипига ЛА, Козлова КН, Звонова ИА, и др. География и структура центров ядерной медицины на территории Российской Федерации по состоянию на 2025 г. Радиационная гигиена. 2025;18(2):98-108.Chipiga LA, Kozlova KN, Zvonova IA, et al. The geography and structure of nuclear medicine centres in the Russian Federation in 2025. Radiation Hygiene. 2025;18(2):98-108. https://doi.org/10.21514/1998-426X-2025-18-2-98-108. (In Russ.).Морозов СП, Смолярчук МЯ, ВладзимирскийАВ. ПЭТ/КТ в здравоохранении Москвы: оснащенность, используемость, доступность. REJR 2018; 8(3):318-24.Morozov SP, Smolyarchuk MY, Vladzimirskiy AV. PET/CT in Moscow healthcare: Equipment, utilization, and accessibility. REJR. 2018;8(3):318-24. https://doi.org/10.21569/2222-7415-2018-8-3-318-324. (In Russ.).Завадовский КВ, Веснина ЖВ, Анашбаев ЖЖ, и др. Современное состояние ядерной кардиологии в Российской Федерации. Российский кардиологический журнал. 2022;27(12):5134.Zavadovsky KV, Vesnina ZhV, Anashbaev ZhZh, et al. Current status of nuclear cardiology in the Russian Federation. Russian Journal of Cardiology. 2022;27(12):5134. https://doi.org/10.15829/1560-4071-2022-5134. (In Russ.).Калмыков С.Н. «Мы должны стремиться к тому, чтобы вернуть России былые позиции в ядерной медицине». Ведомости Научного центра экспертизы средств медицинского применения. Регуляторные исследования и экспертиза лекарственных средств. 2022;12(4):356-8.Kalmykov SN. “We should strive to attain Russia’s former standing in nuclear medicine”. Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. Regulatory Research and Medicine Evaluation. 2022;12(4):356-8. https://doi.org/10.30895/1991-2919-2022-12-4-356-358. (In Russ.).Уйба ВВ, Удалов ЮД, Лебедев АО, и др. Перспективы внедрения технологий ядерной медицины в системе ФМБА России. Медицинская радиология и радиационная безопасность. 2019;64(2):5-10.Uiba VV, Udalov YuD, Lebedev AO, et al. Prospects for implementing nuclear medicine technologies within the FMBA of Russia system.Medical Radiology and Radiation Safety. 2019;64(2):5-10. https://doi.org/10.12737/article_5ca58d9b366162.17322538. (In Russ.).Курашвили ЮБ, Каприн АД. Ядерная медицина в России: организационные проблемы и пути их решения. Медицинская физика. 2016;(2):43-46.Kurashvili YuB, Kaprin AD. Nuclear medicine in Russia: organizational challenges and solutions. Medical Physics. 2016;(2):43-46. EDN VZGVUV. (In Russ.).Яновский А. Конкуренция необходима. Московская медицина. 2016;(1):87-89.Yanovsky A. Competition is essential. Moscow Medicine. 2016;(1):87-89. EDN XCEDVL. (In Russ.).Ишутин СВ. Оценка участия проекта государственно-частного партнерства АО «ЕМЦ» в московском здравоохранении по оказанию услуги ПЭТ/КТ-диагностика. Кардиоваскулярная терапия и профилактика. 2022;21(2S):67.Ishutin SV. Assessment of the involvement of the public–private partnership project of «EMC» in PET/CT diagnostics within Moscow healthcare. Cardiovascular Therapy and Prevention. 2022;21(2S):67. https://doi.org/10.15829/1728-8800-2022-S2. (In Russ.).Аксенова ЕИ, Горбатов СЮ, Камынина Н.Н. Глобальное видение устойчивого развития и реформ здравоохранения. Проекты мегаполисов и стран мира: монография [Электронный ресурс]. Москва: ГБУ «НИИОЗММ ДЗМ»; 2023. 93 с. ISBN 978-5-907717-84-8. URL: https://niioz.ru/moskovskaya-meditsina/izdaniya-nii/monografii/ (дата обращения: 04.03.2026).Aksenova EI, Gorbatov SYu, Kamynina NN. Global vision of sustainable development and healthcare reforms: Megacity and national projects worldwide. Moscow: GBU “NIIOZMM DZM”; 2023. 93 p. ISBN 978-5-907717-84-8. URL: https://niioz.ru/moskovskaya-meditsina/izdaniya-nii/monografii/ (In Russ.).Лэнг ТА, Сесик М. Как описывать статистику в медицине: руководство для авторов, редакторов и рецензентов. Пер. с англ. под ред. В.П. Леонова. Москва: Практическая медицина; 2011. ISBN 978-5-98811-173-4. EDN QLYKNZ.Lang TA, Secic M. How to report statistics in medicine: Annotated guidelines for authors, editors, and reviewers. VP Leonov (Ed.). Moscow. 2011. ISBN 978-5-98811-173-4. EDN QLYKNZ. (In Russ.).Буланов НМ, Суворов АЮ, Блюсс ОБ и др. Основные принципы применения описательной статистики в медицинских исследованиях. Сеченовский вестник. 2021;12(3):4-16.Bulanov NM, Suvorov AYu, Blyuss OB, et al. Basic principles of descriptive statistics in medical research. Sechenov Bulletin. 2021;12(3):4-16. https://doi.org/10.47093/2218-7332.2021.12.3.4-16. (In Russ.).da Silva Brandão Rodrigues M, Magne TM, Santos-Oliveira R. Inside Brazilian nuclear medicine: numbers, projections and behaviors. Eur J Nucl Med Mol Imaging. 2023;50(13):3809-16. https://doi.org/10.1007/s00259-023-06386-y.da Silva Brandão Rodrigues M, Magne TM, Santos-Oliveira R. Inside Brazilian nuclear medicine: numbers, projections and behaviors. Eur J Nucl Med Mol Imaging. 2023;50(13):3809-16. https://doi.org/10.1007/s00259-023-06386-y.Ebenhan T, Kleynhans J, Zeevaart JR, et al. Non-oncological applications of RGD-based single-photon emission tomography and positron emission tomography agents. Eur J Nucl Med Mol Imaging. 2021;48(5):1414-33. https://doi.org/10.1007/s00259-020-04975-9.Ebenhan T, Kleynhans J, Zeevaart JR, et al. Non-oncological applica­tions of RGD-based single-photon emission tomography and posi­tron emission tomography agents. Eur J Nucl Med Mol Imaging. 2021;48(5):1414-33. https://doi.org/10.1007/s00259-020-04975-9.Han EJ, Lim CH, Oh J, et al. 18F-FDG PET/CT for Oncological Patients: Procedural Guideline by the Korean Society of Nuclear Medicine Version 2.0. Nucl Med Mol Imaging. 2025;59(6):377-88. https://doi.org/10.1007/s13139-025-00928-y.Han EJ, Lim CH, Oh J, et al. 18F-FDG PET/CT for Oncological Patients: Procedural Guideline by the Korean Society of Nuclear Medicine Version 2.0. Nucl Med Mol Imaging. 2025;59(6):377-88. https://doi.org/10.1007/s13139-025-00928-y.Suzuki K, Miyake H, Inaki A, et al. Policy recommendations for promoting nuclear medicine therapy in Japan 2025, from the Working Group for promoting nuclear medicine therapy of the Japan Society of Clinical Oncology. Int J Clin Oncol. 2025;30(11):2168-77. https://doi.org/10.1007/s10147-025-02858-3.Suzuki K, Miyake H, Inaki A, et al. Policy recommendations for pro­moting nuclear medicine therapy in Japan 2025, from the Working Group for promoting nuclear medicine therapy of the Japan Society of Clinical Oncology. Int J Clin Oncol. 2025;30(11):2168-77. https://doi.org/10.1007/s10147-025-02858-3.Kefallonitou D, Polycarpou I, Souliotis K, et al. Integrating a Positron Emission Tomography/Computed Tomography Into the National Health System of Cyprus: Will It Return on Its Investment? Front Public Health. 2021;9:607761. https://doi.org/10.3389/fpubh.2021.607761.Kefallonitou D, Polycarpou I, Souliotis K, et al. Integrating a Posi­tron Emission Tomography/Computed Tomography Into the Na­tional Health System of Cyprus: Will It Return on Its Investment? Front Public Health. 2021;9:607761. https://doi.org/10.3389/fpubh.2021.607761.

The authors declare that there are no conflicts of interest present.